Scarica l'app Stockscreener
142.97
1.33%
1.7514
Precedente Chiudi:
$141.22
Aprire:
$142.83
Volume 24 ore:
1.03M
Relative Volume:
0.62
Capitalizzazione di mercato:
$26.30B
Reddito:
$15.41B
Utile/perdita netta:
$1.37B
Rapporto P/E:
19.06
EPS:
7.5
Flusso di cassa netto:
$2.11B
1 W Prestazione:
-4.06%
1M Prestazione:
-23.02%
6M Prestazione:
-37.32%
1 anno Prestazione:
-38.14%
Intervallo 1D:
$137.78
$143.62
Intervallo di 1 settimana:
$137.49
$151.49
Portata 52W:
$135.97
$252.88
Iqvia Holdings Inc Stock (IQV) Company Profile
Nome
Iqvia Holdings Inc
Settore
Industria
Telefono
919-998-2000
Indirizzo
2400 ELLIS ROAD, DURHAM, NC
Confronta IQV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
142.97 | 26.30B | 15.41B | 1.37B | 2.11B | 7.50 |
|
TMO
Thermo Fisher Scientific Inc
|
433.46 | 166.47B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
193.79 | 135.88B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
421.55 | 32.74B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
102.83 | 29.40B | 6.53B | 1.26B | 1.31B | 4.35 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-10 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-02-03 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-12-20 | Iniziato | Stephens | Overweight |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-09-04 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-07-24 | Downgrade | Jefferies | Buy → Hold |
| 2024-06-06 | Iniziato | Goldman | Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-02-15 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-02-13 | Iniziato | BTIG Research | Buy |
| 2023-11-02 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-03-17 | Iniziato | Truist | Buy |
| 2022-12-06 | Iniziato | Cowen | Outperform |
| 2022-11-17 | Downgrade | Citigroup | Buy → Neutral |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-07-15 | Iniziato | SVB Leerink | Outperform |
| 2022-05-24 | Iniziato | Guggenheim | Buy |
| 2022-04-29 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-04-16 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2021-03-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2020-07-07 | Iniziato | Stephens | Equal-Weight |
| 2020-03-02 | Iniziato | Deutsche Bank | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-12-13 | Aggiornamento | CFRA | Sell → Hold |
| 2019-11-14 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2019-06-21 | Aggiornamento | Mizuho | Neutral → Buy |
| 2019-05-28 | Iniziato | SVB Leerink | Outperform |
| 2019-01-18 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-10-09 | Iniziato | UBS | Buy |
| 2018-10-02 | Reiterato | Robert W. Baird | Outperform |
| 2018-07-25 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2018-07-25 | Reiterato | Stifel | Buy |
| 2018-07-03 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2018-04-13 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-03-07 | Aggiornamento | SunTrust | Hold → Buy |
| 2018-01-19 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
Iqvia Holdings Inc Borsa (IQV) Ultime notizie
First Week of June 20th Options Trading For IQVIA Holdings (IQV) - Nasdaq
Here's What to Expect from IQVIA Holdings' Next Earnings Report - Nasdaq
IQVIA to Announce First-Quarter 2025 Results on May 6, 2025 - 01net
IQVIA to Announce First-Quarter 2025 Results on May 6, 2025 | IQV Stock News - GuruFocus
IQVIA First Quarter 2025 Earnings Coming May 6Key Details for Investors - Stock Titan
Here's What To Expect From IQVIA Holdings' Next Earnings Report - Barchart.com
Jefferies Adjusts Price Target on IQVIA Holdings to $165 From $205, Maintains Hold Rating - marketscreener.com
(IQV) On The My Stocks Page - news.stocktradersdaily.com
Record-Breaking $102B Biopharma R&D Investment Signals Industry Recovery - Stock Titan
Bank of America Adjusts Price Target for Iqvia (IQV) to $190 | I - GuruFocus
Barclays Downgrades Iqvia (IQV) Amid Concerns Over Pharma Tariffs | IQV Stock News - GuruFocus
Truist cuts IQVIA stock price target to $216, keeps Buy rating - Investing.com Canada
IQVIA (IQV) Moves 8.7% Higher: Will This Strength Last? - Yahoo Finance
IQVIA (IQV) Downgraded by Barclays Over Tariff Concerns - GuruFocus
Truist Adjusts IQVIA Holdings' PT to $216 From $263, Keeps Buy Rating - marketscreener.com
Iqvia, Icon, Fortrea downgraded at Barclays on tariff overhang - Seeking Alpha
Truist Lowers Iqvia (IQV) Price Target Amid CRO Sector Challenges | IQV Stock News - GuruFocus
Barclays Downgrades IQVIA Holdings to Equalweight From Overweight, Adjusts PT to $170 From $235 - marketscreener.com
Barclays cuts IQVIA stock rating, slashes price target to $170 By Investing.com - Investing.com South Africa
Barclays cuts IQVIA stock rating, slashes price target to $170 - Investing.com Australia
Evercore ISI Adjusts Price Target on IQVIA Holdings to $165 From $245, Maintains Outperform Rating - MarketScreener
Goldman Sachs Adjusts IQVIA Holdings Price Target to $200 From $230, Maintains Buy Rating - MarketScreener
IQVIA Holdings Inc. (IQV): Among Stocks with Buy Ratings that Hedge Funds Love - Insider Monkey
IQVIA Holdings (NYSE:IQV) Sees 13% Weekly Price Dip Amid Credit Agreement Amendment - Yahoo
Leerink Partners Adjusts IQVIA Holdings Price Target to $245 From $259, Maintains Outperform Rating - marketscreener.com
Decentralized TrialsHybrid & Virtual Trials Solution - IQVIA
Earnings grew faster than the respectable 6.4% CAGR delivered to IQVIA Holdings (NYSE:IQV) shareholders over the last five years - Yahoo Finance
IQVIA Holdings Inc.'s (NYSE:IQV) Shareholders Might Be Looking For Exit - simplywall.st
Is IQVIA Holdings (NYSE:IQV) A Risky Investment? - Yahoo Finance
Truist Financial Remains a Buy on IQVIA Holdings (IQV) - The Globe and Mail
IQV stock touches 52-week low at $179.23 amid market challenges - Investing.com India
Here's Why Investors Must Hold IQV Stock in Their Portfolios Now - TradingView
What Is IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Doing? - Yahoo Finance
Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks - Yahoo Finance
Why IQVIA Holdings Inc. (IQV) is Among the Best Diagnostics Stocks to Invest in Right Now - Insider Monkey
Boasting A 23% Return On Equity, Is IQVIA Holdings Inc. (NYSE:IQV) A Top Quality Stock? - Yahoo
Long Term Trading Analysis for (IQV) - news.stocktradersdaily.com
IQVIA Holdings (IQV) Fell on Lowered Guidance - MSN
3 Reasons IQV is Risky and 1 Stock to Buy Instead - Yahoo Finance
IQVIA Holdings Inc.'s (NYSE:IQV) Intrinsic Value Is Potentially 100% Above Its Share Price - Yahoo Finance
Sequoia Financial Advisors LLC Grows Position in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
Mizuho Adjusts Price Target on IQVIA Holdings to $242 From $247, Maintains Outperform Rating - Marketscreener.com
Is IQVIA Holdings Stock Underperforming the Dow? - Nasdaq
Jones Financial Companies Lllp Buys 441 Shares of IQVIA Holdings Inc. (NYSE:IQV) - Defense World
Is IQVIA Holdings Stock Underperforming The Dow? - Barchart.com
Victory Capital Management Inc. Sells 9,038 Shares of IQVIA Holdings Inc. (NYSE:IQV) - Defense World
IQVIA (NYSE:IQV) Downgraded to “Hold” Rating by StockNews.com - Defense World
Argus Adjusts IQVIA Holdings Price Target to $245 From $260, Maintains Buy Rating -March 11, 2025 at 09:47 am EDT - Marketscreener.com
Iqvia Holdings Inc Azioni (IQV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.13%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):